Immuno-Oncology: The Science of Hope



Breakthrough therapies are transforming cancer care

Immuno-oncology drugs are fundamentally changing oncology treatment, yielding important anti-tumor responses and revealing the immune system’s power to defeat cancer. In our white paper, you’ll follow the evolution of immunotherapy molecules and checkpoint inhibitors, examine ways to measure patient responses, and discover why therapeutic vaccines are an especially big challenge. You’ll learn:

  • How a thorough understanding of tumor immunology is critical to development of immuno-oncology drugs
  • The role of immunoediting, based on the premise that the immune system protects the host and shapes tumor immunogenicity
  • Why development of immune checkpoint inhibitors in solid tumors is a turning point in immunotherapy research